TAK-058

ENV8058 · Takeda

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for TAK-058, covering 2015-12-17 to 2017-05-01. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of TAK-058 and Ondansetron on P50 Auditory Gating in Participants With Stable Schizophrenia [Phase 1]